|
|
|
|
 |
|
|
|
|
|
|
|
|
|
| |
OBA, which supports the Office of Science Policy, within the Office of the Director of NIH:
|
|
|
| |
 |
Monitors scientific progress in human genetics research in order to anticipate future developments, including ethical, legal, and social concerns, in basic and clinical research involving Recombinant DNA and Genetic Technologies;
|
|
|
| |
|
Manages the operation of, and provides analytical support to, the NIH Recombinant DNA Advisory Committee, the DHHS Secretary's Advisory Committee on Genetics, Health, and Society;
|
|
|
| |
|
Coordinates and provides liaison with Federal and non-Federal national and international organizations concerned with Recombinant DNA, Human Gene Transfer, and Genetic Technologies;
|
|
|
| |
|
Provides advice to the NIH Director, other Federal agencies, and State regulatory organizations concerning Recombinant DNA research, Human Gene Transfer, and Genetic Technologies;
|
|
|
| |
|
Responds to requests for information on highly technical matters and matters of public policy related to Recombinant DNA, Human Gene Transfer, and Genetic Technologies;
|
|
|
| |
|
Develops and implements NIH policies and procedures for the safe conduct of Recombinant DNA Activities, and Human Gene Transfer;
|
|
|
| |
|
Reviews and evaluates the composition of Institutional Biosafety Committees; and
|
|
|
| |
|
Develops registries of activities related to Recombinant DNA Research and Human Gene Transfer.
|
|
|
|
|
